HY-112100-10mg
|
MedChemexpress LLC
|
PAC [CAS 2158322-33-7]
|
|
Cancer-programmed cell death
|
|
HY-112100-5mg
|
MedChemexpress LLC
|
PAC [CAS 2158322-33-7]
|
|
Cancer-programmed cell death
|
|
HY-126686-10mg
|
MedChemexpress LLC
|
Mal-Phe-C4-VC-PAB-MMAE [CAS 2259318-51-7]
|
|
Cancer-programmed cell death
|
|
HY-126686-100mg
|
MedChemexpress LLC
|
Mal-Phe-C4-VC-PAB-MMAE [CAS 2259318-51-7]
|
|
Cancer-programmed cell death
|
|
HY-126686-25mg
|
MedChemexpress LLC
|
Mal-Phe-C4-VC-PAB-MMAE [CAS 2259318-51-7]
|
|
Cancer-programmed cell death
|
|
HY-126686-5mg
|
MedChemexpress LLC
|
Mal-Phe-C4-VC-PAB-MMAE [CAS 2259318-51-7]
|
|
Cancer-programmed cell death
|
|
HY-126686-50mg
|
MedChemexpress LLC
|
Mal-Phe-C4-VC-PAB-MMAE [CAS 2259318-51-7]
|
|
Cancer-programmed cell death
|
|
HY-126690-1mg
|
MedChemexpress LLC
|
DBCO-(PEG2-VC-PAB-MMAE)2 [CAS 2259318-55-1]
|
|
Cancer-programmed cell death
|
|
HY-126690-10mg
|
MedChemexpress LLC
|
DBCO-(PEG2-VC-PAB-MMAE)2 [CAS 2259318-55-1]
|
|
Cancer-programmed cell death
|
|
HY-126690-5mg
|
MedChemexpress LLC
|
DBCO-(PEG2-VC-PAB-MMAE)2 [CAS 2259318-55-1]
|
|
Cancer-programmed cell death
|
|
HY-130442-100mg
|
MedChemexpress LLC
|
Mal-PEG2-acid [CAS 1374666-32-6]
|
|
Cancer-programmed cell death
|
|
HY-130442-25mg
|
MedChemexpress LLC
|
Mal-PEG2-acid [CAS 1374666-32-6]
|
|
Cancer-programmed cell death
|
|
HY-130442-250mg
|
MedChemexpress LLC
|
Mal-PEG2-acid [CAS 1374666-32-6]
|
|
Cancer-programmed cell death
|
|
HY-130442-50mg
|
MedChemexpress LLC
|
Mal-PEG2-acid [CAS 1374666-32-6]
|
|
Cancer-programmed cell death
|
|
HY-141604-1mg
|
MedChemexpress LLC
|
GlembatuMu mab vedotin [CAS 1182215-65-1]
|
|
Cancer-programmed cell death
|
|
HY-141604-5mg
|
MedChemexpress LLC
|
GlembatuMu mab vedotin [CAS 1182215-65-1]
|
|
Cancer-programmed cell death
|
|
HY-147271-1mg
|
MedChemexpress LLC
|
Mal-PEG8-Val-Ala-PAB-Exatecan [CAS 2679821-39-5]
|
|
Cancer-programmed cell death
|
|
HY-147271-10mg
|
MedChemexpress LLC
|
Mal-PEG8-Val-Ala-PAB-Exatecan [CAS 2679821-39-5]
|
|
Cancer-programmed cell death
|
|
HY-147271-5mg
|
MedChemexpress LLC
|
Mal-PEG8-Val-Ala-PAB-Exatecan [CAS 2679821-39-5]
|
|
Cancer-programmed cell death
|
|
HY-148127-1mg
|
MedChemexpress LLC
|
TAM558 [CAS 1802499-21-3]
|
|
Cancer-programmed cell death
|
|
HY-148127-10mg
|
MedChemexpress LLC
|
TAM558 [CAS 1802499-21-3]
|
|
Cancer-programmed cell death
|
|
HY-148127-5mg
|
MedChemexpress LLC
|
TAM558 [CAS 1802499-21-3]
|
|
Cancer-programmed cell death
|
|
HY-150233-1mg
|
MedChemexpress LLC
|
Cys-McMMAF [CAS 1160590-05-5]
|
|
Cancer-programmed cell death
|
|
HY-150233-10mg
|
MedChemexpress LLC
|
Cys-McMMAF [CAS 1160590-05-5]
|
|
Cancer-programmed cell death
|
|
HY-150233-5mg
|
MedChemexpress LLC
|
Cys-McMMAF [CAS 1160590-05-5]
|
|
Cancer-programmed cell death
|
|